ConductScience.org, home

Paper · 42657158

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136927642EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.Ann Rheum Dis2024https://conductscience.org/library/papers/36927642PubMed
240656763Burden of hypereosinophilic syndromes in the United States: Patients' perspective.J Allergy Clin Immunol Glob2025https://conductscience.org/library/papers/40656763PubMed
336530646Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases.J Patient Exp2022https://conductscience.org/library/papers/36530646PubMed
437064032Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.Front Med (Lausanne)2023https://conductscience.org/library/papers/37064032PubMed
541242921Mepolizumab improves health-related quality of life in patients with hypereosinophilic syndrome.Eur J Intern Med2026https://conductscience.org/library/papers/41242921PubMed
637605658Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients.Cureus2023https://conductscience.org/library/papers/37605658PubMed
734389506Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.J Allergy Clin Immunol Pract2021https://conductscience.org/library/papers/34389506PubMed
838532489Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma.Allergy Asthma Clin Immunol2024https://conductscience.org/library/papers/38532489PubMed
937419574HES and EGPA: Two Sides of the Same Coin.Mayo Clin Proc2023https://conductscience.org/library/papers/37419574PubMed
1026475367Hypereosinophilic Syndrome.Clin Rev Allergy Immunol2016https://conductscience.org/library/papers/26475367PubMed
1137161084Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.Nat Rev Rheumatol2023https://conductscience.org/library/papers/37161084PubMed
1240886121Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab.ACR Open Rheumatol2025https://conductscience.org/library/papers/40886121PubMed
1339508562Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS study.Mod Rheumatol2025https://conductscience.org/library/papers/39508562PubMed
1440499922The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.Rheumatology (Oxford)2025https://conductscience.org/library/papers/40499922PubMed
1532956756Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.J Allergy Clin Immunol2020https://conductscience.org/library/papers/32956756PubMed
1618344568Treatment of patients with the hypereosinophilic syndrome with mepolizumab.N Engl J Med2008https://conductscience.org/library/papers/18344568PubMed
1742367662Patient perspectives on glucocorticoid-associated complications and sequelae in ANCA-associated vasculitis.EULAR Rheumatol Open2025https://conductscience.org/library/papers/42367662PubMed
1829055500Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.Clin Ther2017https://conductscience.org/library/papers/29055500PubMed
1925205825Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.Rheumatology (Oxford)2015https://conductscience.org/library/papers/25205825PubMed
2042367648Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial.EULAR Rheumatol Open2025https://conductscience.org/library/papers/42367648PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/42657158/references